Akzo Nobel (ENXTAM:AKZA) Could Be 7% Undervalued As AI R And D Push Draws Focus
Akzo Nobel (ENXTAM:AKZA) has drawn fresh attention after announcing an AI-focused partnership with Albert Invent to support its global R&D operations through the Digital Workbench platform.
See our latest analysis for Akzo Nobel.
The AI partnership news comes after a mixed period for Akzo Nobel’s stock, with the share price at €57.40, a 90 day share price return of 10.13% pointing to improving short term momentum, while the 1 year total shareholder return declined 1.40% and the 5 year total shareholder return declined 37.15%.
If this kind of AI driven R&D shift has your attention, it could be a good moment to look across other AI focused opportunities using our screener of 63 profitable AI stocks that aren't just burning cash
Akzo Nobel is clearly investing in its R&D strength through AI, but a stronger toolkit in the lab does not automatically make the stock good value at €57.40. How does the current price compare with the fundamentals?
Most Popular Narrative: 7% Undervalued
The most followed valuation narrative for Akzo Nobel puts fair value at €61.71, compared with the last close at €57.40. This frames the current price as below that reference point while still close to analyst expectations overall.
The analysts have a consensus price target of €61.71 for Akzo Nobel based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €73.0, and the most bearish reporting a price target of just €50.0.
Want to see what is sitting underneath this fair value gap for Akzo Nobel? The narrative is built on moderate revenue growth, firmer margins and a future earnings multiple that has to be justified by delivery. Curious how those moving parts fit together in the cash flow model and price target logic?
Result: Fair Value of €61.71 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, investors still need to weigh risks such as weaker volumes in mature markets and tougher price competition in coatings, which could challenge the current Akzo Nobel narrative.
Find out about the key risks to this Akzo Nobel narrative.
Next Steps
If the mixed signals around Akzo Nobel have you unsure, now is a good time to look through the numbers yourself and judge the balance of risks and rewards. To see that balance laid out clearly, including both concerns and potential upsides investors are watching, review the 4 key rewards and 4 important warning signs
Looking for more Akzo Nobel style investment ideas?
If Akzo Nobel has sparked your interest, do not stop at a single stock. Cast the net wider with a few focused screens tailored to different priorities.
- Target steadier potential by reviewing companies in our 296 resilient stocks with low risk scores that aim to limit drawdowns while still offering meaningful exposure to equities.
- Hunt for pricing gaps where fundamentals and share prices do not fully align by scanning the 211 high quality undervalued stocks and comparing candidates side by side.
- Spot earlier stage opportunities with room to mature by working through the screener containing 499 high quality undiscovered gems and shortlisting ideas that fit your risk profile.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com